Cotización Raiffeisen Bank - RBIV | ADVFN

US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

Raiffeisen Bank International Ag (RBIV)

18.29

0.71

(4.04%)

Cerrado 30 Julio 10:30AM

Realtime Data

Su centro para precios en tiempo real, ideas y debates en vivo

Último Precio

18.29

Postura de Compra

18.26

Postura de Venta

18.35

Volume Operado de la Acción

47,387

18.18 Rango del Día 19.03

0.00 Rango de 52 semanas 0.00

Precio Anterior

17.58

Precio de Apertura

18.20

Hora

Última hora de negociación

Volumen promedio (3 m)

-

Volumen financiero

885,390 €

Precio Promedio Ponderado

18.6842

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Royalty Pharma Appoints Molly Sawaya as Executive Vice President, Head of Human Capital

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the appointment of Molly Sawaya as Executive Vice President, Head of Human Capital. Molly joins...

Royalty Pharma to Announce Second Quarter 2024 Financial Results on August 8, 2024

NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2024 financial results on Thursday, August 8, 2024 before the...

Royalty Pharma Declares Third Quarter 2024 Dividend

NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2024 of $0.21 per Class A...

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form 8-K - Current report

Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

NEW YORK, June 04, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ASAOAtlantic Sapphire ASA	kr 6.071 (20.22%)	454
ATOPAtos SE	1.007 € (16.60%)	149.82k
EKIPEkinops	3.315 € (10.68%)	6.68k
BIOPOCBioporto A S	kr 2.46 (10.07%)	548
RDCDRedcare Pharmacy NV	145.30 € (8.92%)	9.72k
LOCALPSolocal Groupe	0.00555 € (-38.33%)	2.11M
XSPRASXSpray Pharma AB	SEK 52.00 (-12.46%)	3k
INTRUSIntrum AB	SEK 44.87 (-11.39%)	88.13k
BNNDBRAIN Biotech AG	2.11 € (-10.97%)	97
BOULSBoule Diagnostics AB	SEK 9.14 (-10.39%)	22
SASSSAS AB	SEK 0.0242 (-1.63%)	15.81M
ISPMIntesa Sanpaolo Spa	3.7975 € (3.28%)	6.37M
TITMTelecom Italia SpA	0.2307 € (0.74%)	2.53M
SANEBanco Santander SA	4.512 € (0.82%)	2.25M
BCPUBanco Comercial Portugues SA	0.3864 € (0.34%)	2.13M

Hosai

Hosai 44 segundos hace

I prob was too leading in my question but gemini seems to agree that Anavex should have prob been more precise, I still think it's prob calander year but emailed IR just in-case.

"if a company has a year end of 30th september, and they talk about an event being expected to happen in Q

PioneerCorsair42

PioneerCorsair42 54 segundos hace

There’ll be a big volume day when there’s capitulation.

exwannabe

exwannabe 56 segundos hace

The patent does not get extended.

The patent on the subQ version is a different patent with its own expiration. So the market would have generic infusion based nivolumab competing against Opdivo and Opdivo SQ.. If patients and docs prefer SQ then they have a winner.

Thi

KVM

KVM 58 segundos hace

Totally disagree. May get both but 100% sure stock offering in some form in the works.

Monksdream

Monksdream 1 minuto hace

AZTR new 52 week low
https://investorshub.advfn.com/uimage/uploads/2024/7/30/wuwubIMG_0134.gif

poster44ny

poster44ny 1 minuto hace

$HHSE ANNOUNCED UPCOMING $10M FUNDING

1). LETTER OF INTENT TERMS FOR UP TO $10-MM CORPORATE FINANCING – The Board reviewed a financing proposal for the company, which was presented by a well-known and respected New York-based private equity fund (the “Special Ventures” partner). The

WOW23P

WOW23P 1 minuto hace

I think so too, Chil. Are we both dilusional? Calm before the storm (thursday morn)

Pharma Karma!!

fink

fink 1 minuto hace

No worries. I'll sell you your shares back at .015 with the shares I bought from you at .0047

I'll hold them tight for ya.

chumfm

chumfm 1 minuto hace

Roger tries to pump it up everytime he see's increased volumes.The problem is he says the same things over and over.He never answers the question about share price or dividends.Always spewing old news that amounts to nothing.This is why you are at 20 cents and falling.He will keep printing shares to

timberwolf7

timberwolf7 2 minutos hace

Notice WHO likes to say conservatives are 'weird'??
But then you take a look at the ones speaking and go....LOL

https://media.gab.com/cdn-cgi/image/width=568,quality=100,fit=scale-down/system/media_attachments/files/164/318/786/original/624e495fcaa13b9d.jpeg

jammy32

jammy32 2 minutos hace

You should add number 47 - continue to kick the can.

Look at CC from 2017. We are working toward the Nasdaq. Hmmmm

WhatUPWhatUP

WhatUPWhatUP 2 minutos hace

you should be good, because you're not buying or selling at all right?

DTGoody

DTGoody 2 minutos hace

It could be a lot worse as folks could have been holding JAGX at $4.90 per share last week and now are trading @ just over a Dollar. It's not just the OTC's that get beaten up. AFFU will be just fine in the long run. These are some great prices to be acquiring shares here.

dstock07734

dstock07734 2 minutos hace

Penny Stocks 2.0

Penny Stocks 2.0 2 minutos hace

.0117 up, she's thin $ADIA

leverage102

leverage102 3 minutos hace

NSAV $$$$$. *

Is that NSAVx , or any relation ?

NSAV DA KING CEX $$$$

infamous

infamous 3 minutos hace

yea and 86 mil OS is small for any big move above 1.00 of course! ILAL

bob4uall

bob4uall 3 minutos hace

Yes, no more BZWR stock after closing.

The July Agreement with IPSI could say that BZWR must file, but I don’t know why it would. Since they don’t intend to trade as BZWR anymore, why take the time and expense?

Acme Investments

Acme Investments 3 minutos hace

Ahhh......my old stomping ground!! Cleveland right next to Lake Erie!!

ducci1

ducci1 3 minutos hace

jedijazz

jedijazz 3 minutos hace

$IFUS -Impact Fusion International Inc (IFUS) Press Releases https://www.nasdaq.com/market-activity/stocks/ifus/press-releases

ExtremelyBullishZig

ExtremelyBullishZig 3 minutos hace

LOL...same old lame story. You just cannot admit that you are wrong.

GBR

GBR 3 minutos hace

Just all out neglect and indifference for the shareholder and stock price.

The only good thing I can say is that it doesn't look like a public offering is in the works. I think we see a transaction come earnings.

Raiffeisen Bank

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones